If you have been reading about research chemical and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
| Property | Value | Notes |
|---|---|---|
| Synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
| Common form | Crystalline powder | Supplied in milligram to gram quantities |
| Long-term storage | -20 °C, desiccated, protected from light | Reduces degradation |
| Detection technique | LC-MS/MS | Common in anti-doping and research analysis |
| Regulatory status | Prohibited in sport by WADA | Not approved for human therapeutic use |
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
== Applications == Applications of phage display technology include determination of interaction partners of a protein (which would be used as the immobilised phage "bait" with a DNA library consisting of all coding sequences of a cell, tissue or organism) so that the function or the mechanism of the function of that protein may be determined. Phage display is also a widely used method for in vitro protein evolution (also called protein engineering). As such, phage display is a useful tool in drug discovery. It is used for finding new ligands (enzyme inhibitors, receptor agonists and antagonists) to target proteins. The technique is also used to determine tumour antigens (for use in diagnosis and therapeutic targeting) and in searching for protein-DNA interactions using specially-constructed DNA libraries with randomised segments. Recently, phage display has also been used in the context of cancer treatments - such as the adoptive cell transfer approach. In these cases, phage display is used to create and select synthetic antibodies that target tumour surface proteins. These are made into synthetic receptors for T-Cells collected from the patient that are used to combat the disease. Recently, M13 bacteriophages were genetically engineered to display an anti-GD2 single-chain variable fragment (scFv) derived from the FDA-approved antibody Dinutuximab on their pIII coat protein. The engineered phages were subsequently loaded with hundreds of photosensitizer molecules to selectively deliver the payload to GD2-positive neuroblastoma cells.
== External links == Sharma, Vasundhara; Rao, Lingamallu Jagan Mohan (January 2014). "An Overview on Chemical Composition, Bioactivity and Processing of Leaves of Cinnamomum tamala". Critical Reviews in Food Science and Nutrition. 54 (4): 433–448. doi:10.1080/10408398.2011.587615. PMID 24236996. S2CID 46178245. Pandey, A. K.; Mishra, A. K.; Mishra, A. (22 December 2012). "Antifungal and antioxidative potential of oil and extracts derived from leaves of Indian spice plant Cinnamomum tamala". Cellular and Molecular Biology. 58 (1): 142–147. PMID 23273204. Indian bay-leaf page from Gernot Katzer's Spice Pages
For services to the Bangladeshi Community and to Charity. Elinor Muriel Middlemiss. Chef de Mission, Scotland Commonwealth Games Team. For services to Sport. Christopher Neill Middleton. Operational Delivery Deputy Director, Home Office. For Public and Voluntary Service. Steven Richard Miller. Director of Culture and Heritage, Head of Norfolk Museums Service, Norfolk County Council. For services to Heritage and Tourism. Louisa Jane Mitchell. Chief Executive, West London Zone (WLZ). For services to Children and Young People. Stephen Moffitt. Chief Executive Officer, A New Direction. For services to the Arts and Culture. Alison Jane Moffitt-Robinson. For services to Sports Management and Development in Northern Ireland. Huda Mohamed Yassin. Female Genital Mutilation Specialist Lead Midwife, Whittington Health NHS Trust. For services to Midwifery. Kathryn Ann Morley. Lately Chief Executive Officer, OnSide. For services to Young People. Fiona Bennett Morrison. Lately Community Fund Manager, Scottish and Southern Electricity Renewables. For services to the community in the Scottish Highlands. Doreen Lilian Mortimer. Volunteer Shop Manager, Tenby Lifeboat Station, Royal National Lifeboat Institution. For Voluntary Services. Andrew Bernard Moseley. Service Leader, Department for Work and Pensions. For public service in South East Wales. Peter Mountford. Lately Executive Chairman, Heropreneurs. For voluntary services to Armed Forces Personnel. Denise Murdoch. Senior Operations Manager, Carr Gomm. For services to Older People in Argyll and Bute. Alison Margaret Murray.
In 2005, the JECFA (Joint FAO/WHO Expert Committee On Food Additives) risk-assessment evaluation of ethyl carbamate concluded that the margin of exposure to ethyl carbamate from daily food and alcoholic beverages combined is of concern, and mitigation measures to reduce ethyl carbamate in some alcoholic beverages should continue. Ethyl carbamate exposure through alcoholic beverages has been discussed by multiple health authorities, while the cumulative daily exposure in the typical diet is also an issue of rising concern that merits closer observation. The Korean study concluded that "it would be desirable to closely monitor ethyl carbamate levels in Korean foods and find ways to reduce the daily intake." The following US regulators have mentioned urethane:
== History == Roadie was founded by Marc Gorlin, a co-founder of Kabbage and founder of VerticalOne and Pretty Good Privacy, as a same-day and urgent delivery company in 2014. In January 2015, Roadie launched the first consumer to consumer (C2C) version of its app with a Series A funding round of $10 million. In February, Roadie announced a partnership with Waffle House to designate its restaurants "Roadie Roadhouses", offering a neutral meeting place for drivers and senders. Drivers receive free food and drink through the partnership. In May, late-night host Jimmy Kimmel discussed the Roadie-Waffle House relationship in an opening monologue on Jimmy Kimmel Live!. Roadie's driver network expanded significantly as a result. Roadie closed a Series B round of funding in June, raising $15 million, and its first business to business (B2B) app version launched that November. In 2015, Delta Air Lines signed an agreement with Roadie to deliver mishandled luggage, becoming Roadie’s first enterprise customer. Roadie launched a pilot program with Delta at Daytona Beach International Airport. Since then, the relationship has expanded to include over 70 airports around the United States and a first mile/last mile line haul relationship with Delta Cargo. In 2017, the company signed a deal with The Home Depot, also based in Atlanta, and in February 2019, closed a Series C round of funding. In October 2019, Roadie and Delta Cargo announced a partnership to create a same-day cross-country delivery offering, DASH Door-to-Door, the first of its kind from a U.S. passenger airline.
Sources: en.wikipedia.org
DiCaprio has mentioned growing up poor in a neighborhood plagued with prostitution, crime and violence. He was raised Catholic. DiCaprio attended the Los Angeles Center for Enriched Studies for four years and later Seeds Elementary School. He enrolled at John Marshall High School, but disliked public school and wanted to audition for acting jobs instead. He decided to drop out of high school, and later earned a general equivalency diploma (GED). As a child, DiCaprio wanted to become either an actor or a marine biologist. He chose to pursue acting because he enjoyed imitating people and impersonating characters, and liked seeing people's reactions to his impressions. According to DiCaprio, his interest in performing began at the age of two, when he went onstage at a performance festival and danced spontaneously to a positive response from the crowd. He was also motivated to learn acting when his stepbrother's appearance in a television commercial earned him $50,000. DiCaprio has said in interviews that his first television appearance was in the children's series Romper Room, and that he was dismissed from the show for being disruptive. The show's host has denied that any children were removed from the show in this way. At age 11, DiCaprio almost quit acting to pursue breakdancing, after winning second place in a breakdancing competition in his mother's native Germany. Starting at age 14, he appeared in several commercials for Matchbox cars, which he calls his first role. DiCaprio also appeared in commercials for Kraft Singles, Bubble Yum, and Apple Jacks.
=== Allergy === An allergic reaction, formally known as type 1 hypersensitivity, is the result of an inappropriate immune response triggering inflammation, vasodilation, and nerve irritation. A common example is hay fever, which is caused by a hypersensitive response by mast cells to allergens. Pre-sensitised mast cells respond by degranulating, releasing vasoactive chemicals such as histamine. These chemicals propagate an excessive inflammatory response characterised by blood vessel dilation, production of pro-inflammatory molecules, cytokine release, and recruitment of leukocytes. Severe inflammatory response may mature into a systemic response known as anaphylaxis.
sulfur amino acid metabolic processes DNA methylation methionine metabolic processes methionine biosynthetic processes methylation S-adenosylmethionine (SAM) cycle homocysteine catabolic processes folic acid metabolic processes oxidation-reduction processes negative regulation of cystathionine beta-synthase activity.
Locomotive. Vossloh Locomotives (owned by Chinese CRRC) manufactures three models of diesel-hydraulic (G6, G12, G18) and two models of diesel-electric (DE12, DE18) locomotives. Other manufacturer was Voith Turbo Lokomotivtechnik, but closed in 2014 year. Both firms are in Kiel.
==== Comeback attempt and retirement (2006) ==== On January 23, 2006, the Astros indicated that they would file a claim on an insurance policy on Bagwell's health to collect approximately $15.6 million of the $17 million in salary owed to him for the 2006 season. Days earlier, orthopedic surgeon Dr. James Andrews had performed a physical examination on Bagwell and determined that he had become "completely disabled" and was unable to play baseball again. Because of the language of the policy, the Astros could not release him without losing their settlement, nor could he take the field. The decision effectively eliminated his chances of playing again in the Major Leagues. On March 28, Cigna rejected the claim, contending that because Bagwell had played during 2005 World Series he could not have become more disabled during the period of baseball inactivity characteristic of the offseason. Nonetheless, Bagwell still reported to spring training hoping he could contribute in some way during the upcoming 2006 campaign, and to test the injured shoulder. His mere presence in camp put the Astros' insurance claim into further question, creating an awkward situation between the player and the team. He appeared in 14 spring training games, batting .219 with one double. He never had to make any difficult throws that would place notable stress on his shoulder, as the other infielders shifted toward him. As expected, the Astros put him on the 15-day disabled list in late March with bone spurs in the shoulder.
Sources: en.wikipedia.org
== Pharmacokinetic details == More than 90% of verapamil is absorbed when given orally, but due to high first-pass metabolism, bioavailability is much lower (10–35%). It is 90% bound to plasma proteins and has a volume of distribution of 3–5 L/kg. It takes 1 to 2 hours to reach peak plasma concentration after oral administration. It is metabolized in the liver to at least 12 inactive metabolites (though one metabolite, norverapamil, retains 20% of the vasodilatory activity of the parent drug). As its metabolites, 70% is excreted in the urine and 16% in feces; 3–4% is excreted unchanged in urine. This is a nonlinear dependence between plasma concentration and dosage. Onset of action is 1 to 2 hours after oral dosage, and 3 to 5 minutes after intravenous bolus dosage. Biphasic or triphasic following IV administration; terminal elimination half-life is 2–8 hours. Plasma half-life of 2–8 or 4.5–12 hours after single oral dose or multiple oral doses, respectively. It is not cleared by hemodialysis. It is excreted in human milk. Because of the potential for adverse reaction in nursing infants, nursing should be discontinued while verapamil is administered.
The endocrine reproductive system consists of the hypothalamus, the pituitary, the gonads, and the adrenal glands, with input and regulation from many other body systems. True puberty is often termed "central puberty" because it begins as a process of the central nervous system. A simple description of hormonal puberty is as follows:
== External links == Headquarters of International Organisation – List of International Organisations and their Headquarters Procedural history and related documents, on the "Articles on the Responsibility of International Organizations" in the Historic Archives of the United Nations Audiovisual Library of International Law. World News related documents. on the World News related documents. IGO Search – IGO/NGO google custom search engine built by the Government Documents Round Table (GODORT) of the American Library Association
=== Gut microbiome === In several chronic liver diseases, the gut microbiome, which regulates both the innate and adaptive immune systems, is implicated. This can result in abnormal immunological development and an accumulation of primary bile acids. Using this information a bile-acid–intestinal-microbiota–cholestasis triangle is thought to be involved in the pathogenesis of PBC and PSC. After all, bile acids do modulate the gut microbiota; a disturbance here can result in development and progression of cholestasis. This information has prompted researchers into manipulating the microbiota via antibiotics and probiotics for new treatment options. Some antibiotics examined for PSC include vancomycin, which has extensively studied and reviewed. The usage of the drug is found along with a significant decrease in ALP levels, although the long term clinical benefit is unknown. As biochemistry technology becomes more advanced, promising targets have appeared, prompting numerous studies and trials to evaluate the feasibility. Fibrates, FXR agonists, and norUDCA are all innovative therapies for cholestasis.
Sources: en.wikipedia.org
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.
Research-grade purity indicates a supplier's measured percentage of the intended compound. It does not guarantee safety, sterility, or suitability for human consumption. Buyers should request a certificate of analysis with chromatograms and test methods.
Sports regulators prohibit SR9009 because it is a non-approved substance with potential performance-altering effects. Its presence can be detected in anti-doping testing. Athletes are responsible for substances found in their samples.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.